Jeannie Cahalane
In November 2025, Palo Alto-based Hippocratic AI raised $126 million in a Series C funding round, bringing the company’s valuation to $3.5 billion. The round was led by existing investors General Catalyst and Premji Invest, with participation from Andreessen Horowitz (a16z).
Founded by CEO Munjal Shah, Hippocratic AI is building a safety-first large language model (LLM) designed exclusively for the healthcare sector, differentiating itself from the risks of general-purpose models.
The company’s platform focuses on non-diagnostic, patient-facing AI agents. These agents handle tasks such as patient follow-ups, post-operative care instructions, and explaining test results, aiming to reduce clinical workloads and improve patient outcomes.
The new capital will be used to accelerate the extensive safety testing of its model, scale its operations, and expand its partnerships with health systems and medical providers across the UnitedD States.
Key Details
- Company: Hippocratic AI
- Funding: $126M Series C
- Valuation: $3.5B
- Headquarters: Palo Alto, CA
- Investors: General Catalyst, Premji Invest, Andreessen Horowitz (a16z)
- Use Case: Safety-focused LLM and AI agents for non-diagnostic healthcare tasks
